Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete, page-22

First 22 Last

Share
Profile

Follow
NZ Trader

13,510 Posts.

7311

21/08/24

06:54

Post #: 75294943
Share

Originally posted by KrushingIt: ↑

At current levels, people stand to make multiples ie 10X if they buy shares now.

Suffice to say, I have put my money where my mouth is and have got a sizeable position.

Make no mistake:
a) the tech is excellent - CDH17 is a novel product developed by the pioneers in CAR T addressing major oncology markets with unmet needs; CLTX - CART has already shown strong efficacy signals in patients who were in 4th and 5th line therapy (65% of enrolled patients); NK platform potentially best in class with the MD Anderson trial being evaluated as a first line (triplet) therapy for AML
b) management is excellent - Rebecca and Paul are seasoned campaigners with a huge network;
c) multiple SP inflection points in the coming months including data read outs and FDA interactions;
d) I suspect the upcoming CR will be done at a significant premium to the current SP because pre approval was obtained via an EGM. Presumably this will happen shortly after the first patient is dosed with CHMs lead product (CDH17), which is any day now....and there are no major adverse events with the first patient.

Expand

Great post Krushingit ,, I too have been loading up on CHM so I hope your above analysis is bang on the money

Best of Luck to all holders NZT

CHM Price at posting: 1.7¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

First 22 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $8.060M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
3	4815241	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.4¢	100000	1

View Market Depth

No.	Vol.	Price($)
3	4815241	0.004
40	26959271	0.003
16	15400505	0.002
12	54600000	0.001
0	0	0.000

Price($)	Vol.	No.
0.004	100000	1
0.005	18587873	22
0.006	13384684	15
0.007	3100000	2
0.008	8542434	6

Last trade - 07.02am 27/06/2025 (20 minute delay)

CHM (ASX) Chart

Day chart unavailable

Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete, page-22

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Phase 1/2 CHM CDH17 CAR-T GMP Manufacturing Complete, page-22

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Australia’s gas crisis is here – and dying coal plants aren’t helping

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News